Loading...
ALXB
ALEMS
Market cap3mUSD
, Last price  
EUR
Name

DMS Imaging SA

Chart & performance

D1W1MN
ALXB:ALEMS chart
P/E
—
P/S
—
EPS
0.43
Vol. 1Y
—
Shs. 5Y
132.57%
Rev. 5Y
168.32%
Div Yld LY
—
Div Yld TTM
—
Revenues
50m
+4.20%
7541,683,157604,00001,064,841358,94436,270,00035,271,00040,564,00047,912,00049,922,000
Net income
2m
+237.00%
-2,319-4,429-7,715-12,339,000-11,986,000-14,321,000-15,656,000-1,362,000-241,000-5,578,000-709,000546,0001,840,000
CFO
5m
+81.53%
-2,112-3,377-7,921-13,859,000-12,809,000-13,011,000-12,974,000-1,379,000348,0002,326,000-2,274,0002,555,0004,638,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Belgium, European Medical Solutions specializes in the creation, advancement, and production of medical imaging equipment for both digital radiography and bone density assessment. Its comprehensive product range includes fluoroscopy (R/F) systems, such as the innovative PLATINUM NEO, designed to significantly enhance R/F workflow, and the reliable OPTIMA dRF. The company further provides devices for bone densitometry and detailed body composition analysis, along with components for dedicated chest and skeletal imaging rooms, like floor and ceiling-mounted tube stands. Other offerings extend to portable radiography units, system upgrade kits, C-ARM solutions for mobile operating theaters, and specialized mammography equipment. The organization, which was originally established as DMS Imaging SA in 1979 and is headquartered in Ixelles, Belgium, officially rebranded to European Medical Solutions in June 2024. It currently operates as a subsidiary of Diagnostic Medical Systems S.A.

Related entities

Parent

Key people

Beatrice De Vos
Chairman of the Board
Thierry Legon
Chief Executive Officer, Director
Francois Meurgey
Marketing & Commercialization, Director
Marie-Claire Beckers
Head of Production
Adrian Caplanusi
Senior Medical Director
Sacha Gogev
Head of Quality Control
Sabine Pirotton
Senior Clinical Project Manager
Albert Vicaire
Secretary of the company
Philippe Degeer
Director - Representative of Meusinvest
Henri De Meyer
Director
Jean-Claude Duchateau
Director
Director
Everard van der Straten
Director · since 2019
Gerd Zettlmeissl
Director
IPO date
May 11, 2016
Employees
118
Domiciled in
BE
Incorporated in
BE
Legal address
Avenue Louise 231
Ixelles 1050
BE
Headquarters
9 AVENUE DU CANAL PHILIPPE LAMOUR
GALLARGUES LE MONTUEUX 30660
FR
Previous name
ASIT BioTech SA
Previous name
Biotech Tools SA

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT